Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data.
about
Drug repurposing and human parasitic protozoan diseasesHER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors.Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target.Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy.A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors.Resisting resistance: is there a solution for malaria?A systematic analysis of physicochemical and ADME properties of all small molecule kinase inhibitors approved by US FDA from January 2001 to October 2015.Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon.Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models.Highly efficient and selective phosphorylation of amino acid derivatives and polyols catalysed by 2-aryl-4-(dimethylamino)pyridine-N-oxides--towards kinase-like reactivity.An integrated flow and microwave approach to a broad spectrum protein kinase inhibitor
P2860
Q26999453-833FD4E2-191B-4308-8942-4A0033C47E99Q33976964-7F470518-EE76-45C6-B213-F3C2DAEBA8B2Q35598395-B6678EC5-6D87-4E4E-A711-C394CA1CEF48Q36467783-75260003-A4FD-41AC-BA37-4267A7DEC6E9Q38218298-74D8C10A-C403-4772-BD40-DC69C88FD78AQ38503202-7A20A254-BC92-4279-B952-17E550194AFDQ38755043-90E05E9F-5F04-49B7-B79A-8743A2096156Q38763312-B2C036B4-4EAD-4150-A82D-5D4C64CBCC43Q38859977-4AA56454-C4FA-4E97-A2B8-2E7EC493C91FQ38910326-D13CE852-8E8A-425B-81E1-125D9F78F878Q54320260-C9580B06-F8B0-4C4B-88A9-325E84FA62D3Q57976117-524EB7B1-92FE-4C55-B5A4-F904A52C44F3
P2860
Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Small molecule kinase inhibito ...... view of preclinical ADME data.
@ast
Small molecule kinase inhibito ...... view of preclinical ADME data.
@en
type
label
Small molecule kinase inhibito ...... view of preclinical ADME data.
@ast
Small molecule kinase inhibito ...... view of preclinical ADME data.
@en
prefLabel
Small molecule kinase inhibito ...... view of preclinical ADME data.
@ast
Small molecule kinase inhibito ...... view of preclinical ADME data.
@en
P2860
P1476
Small molecule kinase inhibito ...... view of preclinical ADME data.
@en
P2093
Mehran Fallah Moghaddam
Zhihong O'Brien
P2860
P304
P356
10.1517/17425255.2013.834046
P407
P577
2013-08-31T00:00:00Z